Thomson Rogers' Response to Premier Ford's Proposed Legislation to Protect LTC Home Operators
Toronto, ON, Oct. 21, 2020 (GLOBE NEWSWIRE) -- On October 20, 2020, the Ford Government announced proposed legislation that will protect long-term care home operators against negligence claims by thousands of seniors who have contracted COVID-19 and tragically died at these long-term care homes. The actions taken by the Ford Government will make it more difficult for victims of the tragedy in Ontario's long-term care system to obtain justice.
It is shocking and appalling that Premier Ford would take this action while the Independent Commission continues to review the failings of the long-term care system. Back in June, Premier Ford promised to hold these for-profit long-term care home operators accountable. What has changed?
The legislation will serve to protect long-term care home operators and their insurers who make millions of dollars in profits, annually. It is Ontario's vulnerable seniors who need protection, not the multi-million dollar corporations with government connections.
The legislation makes it clear that claims based in gross negligence can continue. Thomson Rogers has issued class action claims against the most egregious long-term care homes (Altamont Care Community, Camilla Care Community, West Terrace Care Community, Woodbridge Vista Care Community, Carlingview Manor and Extendicare West End Villa.) These homes and their operators have been implicated in the Canadian Armed Forces Report and have been taken over by local hospital authorities for such horrendous acts as:
Staff were observed wearing garbage bags over their clothing in place of personal protective equipment ("PPE");
Limited staff access to PPE and inconsistent PPE practices;
Significant under-staffing and a total failure to implement proper infection control protocols;
Concerns raised regarding staff clinical skills and some personnel, including RPNs, required clinical updates to continue practicing safely;
COVID-positive residents and COVID-negative residents were sharing the same room;
Lack of signage and/or inaccurate signage to show which residents were COVID-positive;
Residents were found to be underfed and had poor nutritional status;
Residents were found with pressure ulcers that were not properly treated as a result of prolonged bed rest;
Many residents were bed bound for several weeks and were not repositioned in bed or washed properly;
Lack of consistent monitoring of hydration and nutritional intake of residents;
High resident room temperatures; and,
Cockroaches present on resident floors and in the kitchen.
There is no basis for the provincial government to be protecting long-term care home operators and their insurers. Such action adds severe insult to the tragedy already suffered by the residents and their families who have been victimised in Ontario's long-term care system.
These claims meet the gross negligence standard and will move forward.
For more information about these class actions please contact: Stephen Birman, Thomson Rogers, [email protected], Phone: 416-868-3137, Robert Ben, Thomson Rogers, [email protected], Phone: 416-868-3168 or Lucy Jackson, Thomson Rogers, [email protected], Phone: 416-868-3154.
For media inquiries please contact Ruth S. Fernandes, [email protected], Phone: 416-868-3190.
Takeda (TSE:4502/NYSE:TAK) today announced that the European Medicines Agency's (EMA) Committee for Medicinal Products for Human Use (CHMP) has recommended the approval of fruquintinib, a selective inhibitor of vascular endothelial growth factor...
NOVA LEAP HEALTH CORP. ("Nova Leap" or "the Company"), a growing home health care organization, is pleased to announce that it has executed a definitive agreement (the "Agreement"), dated April 25, 2024, to acquire a home care services company ("the...
Coya Therapeutics, Inc. ("Coya" or the "Company"), a clinical-stage biotechnology company developing biologics intended to enhance regulatory T cell (Treg) function, announces that Dr. Stanley Appel, M.D., Chairman of Coya's Scientific Advisory...
Adyton Resources Corporation announces that it has filed its financial statements for the three and twelve months ended December 31, 2023 and accompanying Management Discussion and Analysis on its SEDAR profile at www.sedar.com. ...
Gilead Sciences, Inc. today announced the U.S. Food and Drug Administration (FDA) approved an updated label with additional data reinforcing the safety and efficacy profile of Biktarvy® (bictegravir 50 mg/emtricitabine 200 mg/tenofovir alafenamide...
The "Global Men's Health and Wellness Market: Analysis By Type, By Distribution Channel, By Region Size & Forecast with Impact Analysis of COVID-19 and Forecast up to 2029" report has been added to ResearchAndMarkets.com's offering.
In 2023, the...